D. Hönemann

发表

Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen

A. Scott, J. Trapani, M. Smyth, 2010, Gene Therapy.

Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice.

A. Scott, J. Trapani, M. Smyth, 2005, Proceedings of the National Academy of Sciences of the United States of America.

The Lewis-Y Carbohydrate Antigen is Expressed by Many Human Tumors and Can Serve as a Target for Genetically Redirected T cells Despite the Presence of Soluble Antigen in Serum

M. Trivett, A. Scott, J. Trapani, 2009, Journal of immunotherapy.

CD38 low IgG‐secreting cells are precursors of various CD38 high‐expressing plasma cell populations

C. Berek, Andreas Radbruch, T. Dörner, 2004, Journal of leukocyte biology.

A novel recombinant bispecific single-chain antibody, bscWue-1 × CD3, induces T-cell-mediated cytotoxicity towards human multiple myeloma cells

B. Dörken, P. Kufer, R. Bargou, 2004, Leukemia.

Determination of the Maximum Tolerated Dose of Panobinostat in Combination with a 5-Day Schedule of Azacitidine in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia: Planned Interim Analysis of a Phase Ib/II Study

A. Wei, O. Gervásio, S. Avery, 2011 .

Enteropathy-associated T-cell lymphoma without a prior diagnosis of coeliac disease: diagnostic dilemmas and management options

R. Hicks, H. Prince, J. Seymour, 2005, Annals of Hematology.

In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway.

B. Dörken, C. Sers, R. Bargou, 2002, Blood.

Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034).

G. Tricot, D. Demarini, A. Roberts, 2009, Blood.

The IL‐6 receptor antagonist SANT‐7 overcomes bone marrow stromal cell–mediated drug resistance of multiple myeloma cells

B. Dörken, R. Savino, R. Burger, 2001, International journal of cancer.

Who is that?! Does Changing the Robot as a Learning Companion Impact Preschoolers' Language Learning?

Nils F. Tolksdorf, K. Rohlfing, D. Hönemann, 2022, 2022 17th ACM/IEEE International Conference on Human-Robot Interaction (HRI).

Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia.

A. Scott, J. Trapani, M. Smyth, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

IgA nephropathy associated with cutaneous T cell lymphoma

S. Lade, H. Prince, C. McCormack, 2009, Leukemia & lymphoma.

On-target restoration of a split T cell-engaging antibody for precision immunotherapy

H. Einsele, H. Wajant, H. Neuweiler, 2019, Nature Communications.

A denileukin diftitox (Ontak) associated retinopathy?

C. Harper, H. Prince, J. Ruddle, 2006, British Journal of Ophthalmology.

A phase II study of liposomal doxorubicin, vincristine and dexamethasone in multiple myeloma

H. Prince, J. Seymour, D. Westerman, 2005, Leukemia & lymphoma.

Gastric involvement of plasmacytoma associated with t(4:14) and chromosome 13 deletion

S. Lade, A. Boussioutas, H. Prince, 2006, Leukemia & lymphoma.

Tumor Lysis Syndrome Early After Treatment with Bortezomib for Multiple Myeloma

H. Prince, D. Hönemann, M. Kenealy, 2006, Pharmacotherapy.

Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034).

G. Tricot, D. Demarini, A. Roberts, 2009, Blood.